Incretin hormones: Revolutionizing the treatment landscape for kidney and liver diseases in type 2 diabetes and obesity

Incretin hormones: Revolutionizing the treatment landscape for kidney and liver diseases in type 2 diabetes and obesity

Saved in:

Bibliographic Details
Main Authors:	Jae Hyun Bae, Young Min Cho
Format:	Article
Language:	English
Published:	Wiley 2025-02-01
Series:	Journal of Diabetes Investigation
Online Access:	https://doi.org/10.1111/jdi.14336
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The associations of incretin hormone concentration with gestational diabetes mellitus
by: Tatiana V. Saprina, et al.
Published: (2016-05-01)

Role of incretin based therapies in the treatment of diabetic kidney disease
by: Paola Fioretto, et al.
Published: (2018-11-01)

Incretin-based therapies for the treatment of obesity-related diseases
by: Irene Caruso, et al.
Published: (2024-11-01)

Incretin hormone agonists as promising antiobesity drugs - review of literature
by: Aleksandra Grzegorczyk, et al.
Published: (2025-01-01)

The role of Leu260Phe polymorphism of the receptor gene to GLP-1 incretin in the pathogenesis of diabetes type 2 diabetes with obesity
by: Daria A. Skuratovskaia, et al.
Published: (2019-08-01)

New glance at pathogenesis of type 2 diabetes mellitus: incretin and antiincretin systems.
by: Ekaterina Alekseevna Shestakova
Published: (2011-09-01)

Effect of nipa palm (Nypa fruticans Wurmb.) vinegar on the incretin hormones and intestinal glucose transporters in type 2 diabetes mellitus rat model
by: Nur Izzati Razali, et al.
Published: (2025-05-01)

Incretin-Based Therapy for Prevention of Diabetic Vascular Complications
by: Akira Mima
Published: (2016-01-01)

Recent clinical and pharmacological advancements of incretin-based therapy and the effects of incretin on physiology
by: Bhaskar Pal, et al.
Published: (2024-01-01)

Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis.
by: Je-Yon Kim, et al.
Published: (2016-01-01)

Incretin-based approaches for type 2 diabetes therapy: effects on circulating cytokines and adipocyte’s secretome
by: Margarita Agareva, et al.
Published: (2025-07-01)

The Application of Incretin-Based Pharmacotherapy in the Contemporary Management of Type 2 Diabetes: A Review of the Literature
by: Jakub Waszczyński, et al.
Published: (2025-01-01)

Multiagonists of the “incretin axis” as a promising tool for managing cardiometabolic risk in visceral obesity
by: M. A. Druzhilov, et al.
Published: (2022-05-01)

Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progression
by: Sandesh J. Marathe, et al.
Published: (2025-03-01)

Effectiveness for adding or switching from other incretin‐related drugs to oral semaglutide in type 2 diabetes
by: Junko Oya, et al.
Published: (2025-04-01)

The role of incretin-based therapies in the management of type 2 diabetes mellitus: perspectives on the past, present and future
by: Juris J. Meier
Published: (2019-12-01)

Monitoring Sarcopenia With Incretin Receptor Activator Treatment
by: Zachary T. Bloomgarden
Published: (2025-06-01)

Incretin-based therapy: renal effects
by: Anton Ivanovich Korbut, et al.
Published: (2016-01-01)

Mechanisms of neuroprotective action of incretin mimetics
by: Timur Dmitrievich Vlasov, et al.
Published: (2016-01-01)

The Gut Microbiome’s Influence on Incretins and Impact on Blood Glucose Control
by: Ajay S. Dulai, et al.
Published: (2024-11-01)

PANCREATIC AND EXTRA-PANCREATIC EFFECTS OF INCRETINS AND PERSPECTIVES FOR STUDYING ENTEROINSULIN HORMONAL SYSTEM DURING GESTATIONAL DISORDER OF CARBOHYDRATE METABOLISM
by: T. V. Saprina, et al.
Published: (2013-06-01)

Comparative efficacy of incretin drugs on glycemic control, body weight, and blood pressure in adults with overweight or obesity and with/without type 2 diabetes: a systematic review and network meta-analysis
by: Song Liu, et al.
Published: (2025-02-01)

Vasoactive Hormones and the Diabetic Kidney
by: Christine Maric
Published: (2008-01-01)

Incretins today: multiple effects and therapeutic potential
by: Oksana V. Tsygankova, et al.
Published: (2019-03-01)

Does Incretin Agonism Have Sustainable Efficacy?
by: Sok-Ja Janket, et al.
Published: (2024-11-01)

Incretin-Based Therapies and Cancer: What’s New?
by: Sanja Medenica, et al.
Published: (2025-04-01)

Impact of Incretin Mimetics on Thyroid Cancer Among Patients with Type 2 Diabetes: A Retrospective Cohort Time-to-Event Analysis
by: Michael W. Strand, et al.
Published: (2025-04-01)

The Acute Impact of Ingestion of Sourdough and Whole-Grain Breads on Blood Glucose, Insulin, and Incretins in Overweight and Obese Men
by: Anita Mofidi, et al.
Published: (2012-01-01)

SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application
by: Jae Hyun Bae
Published: (2025-05-01)

Incretin Effect in Women with Former Gestational Diabetes within a Short Period after Delivery
by: G. Pacini, et al.
Published: (2012-01-01)

Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies
by: Vincenzo Trapanese, et al.
Published: (2025-05-01)

Parboiled Rice and Glycemic Control: Effects on Postprandial Glucose, Insulin Sensitivity, and Incretin Response in Healthy and Type 2 Diabetic Individuals, a Pilot Study
by: Sara Alkandari, et al.
Published: (2025-05-01)

Association between incretin-based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: A large population-based matched cohort study
by: Arunkumar Krishnan, et al.
Published: (2024-12-01)

The Impact of Obesity on the Association between Parity and Risk of Type 2 Diabetes Mellitus
by: Yuki Gen, et al.
Published: (2025-07-01)

Mortality and Heart Failure Exacerbations With Incretin-Mimetic Drugs for Weight Loss in Patients With Obesity-Related Heart Failure With Preserved Ejection Fraction
by: Leila Humphreys, et al.
Published: (2025-05-01)

Symptomatic Adverse Events and Quality of Life Related to Incretin-Based Medicines for Obesity: A Systematic Review Involving >400,000 Subjects
by: Robert F. Kushner, et al.
Published: (2025-04-01)

Association between muscular strength, abdominal obesity, and incident nonalcoholic fatty liver disease in a Korean population
by: Jae Ho Park, et al.
Published: (2025-05-01)

Revolutionizing Autoimmune Kidney Disease Treatment with Chimeric Antigen Receptor-T Cell Therapy
by: Rui Gu, et al.
Published: (2025-01-01)

The postprandial dynamics of gastroduodenal zone hormones in patients with metabolic obesity associated or not associated with type 2 diabetes
by: Elena Vital'evna Kirienkova, et al.
Published: (2015-12-01)

Differences in the insulin counterregulatory hormones between obese and nonobese male patients with type 2 diabetes mellitus
by: Rong Huang, et al.
Published: (2025-04-01)